|
ATP5D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.639600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.612000E-01 |
| Normal-vs-Stage2 |
5.596200E-02 |
| Normal-vs-Stage3 |
9.715200E-01 |
| Normal-vs-Stage4 |
3.182400E-01 |
| Stage1-vs-Stage2 |
1.559950E-02 |
| Stage1-vs-Stage3 |
9.971600E-01 |
| Stage1-vs-Stage4 |
2.464000E-01 |
| Stage2-vs-Stage3 |
5.094100E-02 |
| Stage2-vs-Stage4 |
9.435900E-03 |
| Stage3-vs-Stage4 |
3.576200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.581200E-01 |
| Normal-vs-AfricanAmerican |
9.369200E-01 |
| Normal-vs-Asian |
9.278200E-01 |
| Caucasian-vs-AfricanAmerican |
9.755200E-01 |
| Caucasian-vs-Asian |
8.253000E-01 |
| AfricanAmerican-vs-Asian |
8.921000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.009200E-01 |
| Normal-vs-Female |
8.808000E-01 |
| Male-vs-Female |
2.070000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.323800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.918200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.823800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.301400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.747600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.897600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.547430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.441200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.206400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.153600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.294200E-01 |
| Classical-VS-Follicular |
4.60270000002261E-07 |
| Classical-VS-Other |
2.919800E-01 |
| Classical-VS-Normal |
3.077800E-01 |
| Tall-VS-Follicular |
5.376300E-04 |
| Tall-VS-Other |
2.578000E-01 |
| Tall-VS-Normal |
1.953620E-01 |
| Follicular-VS-Other |
4.324400E-01 |
| Follicular-VS-Normal |
9.356200E-04 |
| Other-VS-Normal |
4.734800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.478200E-02 |
| Normal-vs-N1 |
5.472600E-01 |
| N0-vs-N1 |
5.588600E-01 |
|
|
